Physician profile
Patricia Deitz
NPI 1770734824
$4,012.97
in general payments reported to CMS, 2019-2025
27 companies · $1,035 in 2025
The $1,035 reported for 2025 was more than what 91% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $542 · 2021: $366 · 2022: $570 · 2023: $617 · 2024: $883 · 2025: $1,035.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,469 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,469.00 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $661.24 | 2021-2025 | |
| Abbvie INC. | $576.88 | 2020-2023 | Lo Loestrin Fe, Orilissa, Oriahnn |
| Astellas Pharma US INC | $377.21 | 2023-2025 | Veozah |
| Coopersurgical, INC. | $375.01 | 2022-2025 | Summit Doppler, Paragard T 380a |
| Therapeuticsmd, INC. | $370.37 | 2020-2022 | |
| Biogen, INC. | $205.83 | 2025 | Zurzuvae |
| Pfizer INC. | $193.95 | 2020-2024 | |
| Sumitomo Pharma America, INC. | $142.00 | 2023-2025 | Myfembree, Gemtesa |
| Baxter Healthcare | $134.66 | 2025 | Perclot |
| Bayer Healthcare Pharmaceuticals INC. | $112.20 | 2020-2025 | |
| Radiometer America, INC | $99.16 | 2024-2025 | |
| Exact Sciences Corporation | $98.79 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Exeltis, USA INC. | $87.59 | 2021-2025 | Slynd |
| Millicent US INC | $87.00 | 2024-2025 | Intrarosa, Femring, Femlyv |
| Organon LLC | $80.78 | 2025 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $79.50 | 2021-2025 | Aptima, Thinprep 2000 Processor, Novasure |
| Scynexis, INC. | $63.35 | 2022 | |
| Agile Therapeutics, INC. | $61.02 | 2021-2023 | Twirla |
| Avion Pharmaceuticals | $44.55 | 2022 | |
| Myovant Sciences INC. | $41.38 | 2021-2022 | |
| Shield Therapeutics INC | $22.19 | 2022 | |
| Davol INC. | $21.80 | 2023 | Channel Drain |
| Ibsa Pharma INC. | $21.64 | 2023 | Tirosint, Licart |
| Amag Pharmaceuticals, INC. | $15.98 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.89 | 2023 | Seglentis |
| Lupin INC. | $12.01 | 2020 | |
| Allergan, INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patricia Deitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.